{"id":"NCT02120898","sponsor":"Actavis Inc.","briefTitle":"A Study to Evaluate the Safety and Efficacy Imiquimod Cream, 2.5% in Participants With Actinic Keratoses","officialTitle":"A Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Comparison Study to Determine the Therapeutic Equivalence of Generic Imiquimod Cream, 2.5% and Zyclara® (Imiquimod) Cream, 2.5% in Subjects With Actinic Keratoses","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-10-10","primaryCompletion":"2014-04-30","completion":"2014-04-30","firstPosted":"2014-04-23","resultsPosted":"2019-12-13","lastUpdate":"2019-12-13"},"enrollment":467,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Actinic Keratosis"],"interventions":[{"type":"DRUG","name":"Imiquimod","otherNames":[]},{"type":"DRUG","name":"Zyclara®","otherNames":[]},{"type":"DRUG","name":"Vehicle Cream","otherNames":[]}],"arms":[{"label":"Generic Imiquimod Cream 2.5%","type":"EXPERIMENTAL"},{"label":"Zyclara® (Imiquimod) Cream 2.5%","type":"ACTIVE_COMPARATOR"},{"label":"Vehicle Cream","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study it so compare the safety and efficacy profiles of a generic imiquimod 2.5% cream to the reference listed Zyclara® (imiquimod) cream in the treatment of actinic keratosis (AK).","primaryOutcome":{"measure":"Complete Clearance Rate - Percentage of Participants With Treatment Success: Per-Protocol (PP) Population","timeFrame":"Week 14","effectByArm":[{"arm":"Generic Imiquimod Cream 2.5%","deltaMin":12.4,"sd":null},{"arm":"Zyclara® (Imiquimod) Cream 2.5%","deltaMin":13.6,"sd":null},{"arm":"Vehicle Cream","deltaMin":4.8,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0702"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":17},"locations":{"siteCount":27,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":6,"n":187},"commonTop":["Upper respiratory tract infection","Nasopharyngitis","Application site pain","Fatigue","Sinusitis"]}}